Diagnostic Agreement in Subepidermal Blistering Diseases: Is <scp>ELISA</scp> Test Reliable as Direct Immunofluorescence? A Systematic Review, Meta‐Analysis, and Trial Sequential Analysis
DIF remains the gold standard for the diagnosis of autoimmune SBDs. ELISA can serve as a complementary diagnostic tool, especially as a follow-up instrument for patients with SBD, owing to its low invasiveness.
Authors
- Stefania Leuci (ORCID: https://orcid.org/0000-0003-4468-5083)
- Cosimo Rupe (ORCID: https://orcid.org/0000-0001-9928-4100)
- Romeo Patini (ORCID: https://orcid.org/0000-0001-7358-8763)
- Daniele Gentile (ORCID: https://orcid.org/0009-0000-1862-4821)
- Michele Davide Mignogna (ORCID: https://orcid.org/0000-0002-2021-1775)
- Gioele Gioco (ORCID: https://orcid.org/0000-0002-8637-2029)
- Enrico Di Russo (ORCID: https://orcid.org/0000-0003-3829-6567)
- Anna Schiavelli (ORCID: https://orcid.org/0009-0003-7852-172X)
- Carlo Lajolo (ORCID: https://orcid.org/0000-0003-4663-9734)
- Francesco Scilla (ORCID: https://orcid.org/0009-0000-6418-1320)
Institutions
- University of Siena (IT)
- Università Cattolica del Sacro Cuore (IT)
- University of Rome Tor Vergata (IT)
- Agostino Gemelli University Polyclinic (IT)
- Federico II University Hospital (IT)
- Italian Society of Periodontology and Implantology (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Florence (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Journal of Oral Pathology and Medicine
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1111/jop.70088
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00